Beam Therapeutics Inc.
BEAM
36 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Oct 17 12:09 AM | John M. EvansDirector, CEO | Sale | 25,000 | $23.98 | $599.6K | 1,047,205(D) | View → |
| Oct 15, 2026 | Oct 17 12:09 AM | John M. EvansDirector, CEO | Sale | 25,000 | $23.57 | $589.1K | 1,047,205(D) | View → |
| Oct 16, 2026 | Oct 16 8:12 PM | JOHN M EVANS | Proposed Sale | 25,000 | $23.98 | $599.6K | — | View → |
| Oct 15, 2026 | Oct 15 8:23 PM | JOHN M EVANS | Proposed Sale | 25,000 | $23.57 | $589.1K | — | View → |
| Oct 1, 2026 | Oct 2 8:05 PM | Bethany J CavanaghSVP, Finance and Treasurer | Sale | 187 | $24.41 | $4.6K | 50,984(D) | View → |
| Jul 27, 2026 | Jul 29 8:05 PM | Amy SimonChief Medical Officer | Sale | 16,667 | $25.74 | $429.0K | 85,696(D) | View → |
| Jul 27, 2026 | Jul 27 8:04 PM | AMY SIMON | Proposed Sale | 16,677 | $25.74 | $429.3K | — | View → |
| Jun 30, 2026 | Jul 2 8:05 PM | Amy SimonChief Medical Officer | Sale | 373 | $34.73 | $13.0K | 102,363(D) | View → |
| Jun 30, 2026 | Jul 1 8:05 PM | John M. EvansDirector, CEO | Sale | 25,000 | $34.31 | $857.7K | 1,047,205(D) | View → |
| Jun 29, 2026 | Jul 1 8:05 PM | John M. EvansDirector, CEO | Sale | 25,000 | $35.49 | $887.4K | 1,047,205(D) | View → |
| Jun 30, 2026 | Jun 30 8:19 PM | JOHN M EVANS | Proposed Sale | 25,000 | $34.31 | $857.7K | — | View → |
| Jun 29, 2026 | Jun 29 8:14 PM | JOHN M EVANS | Proposed Sale | 25,000 | $35.49 | $887.4K | — | View → |
| Jun 26, 2026 | Jun 29 6:17 PM | FMR LLC10% Owner, Other | Sale | 251,488 | $35.26 | $8.9M | 854,583(I) | View → |
| Jun 25, 2026 | Jun 29 6:17 PM | FMR LLC10% Owner, Other | Sale | 33,372 | $35.12 | $1.2M | 1,106,071(I) | View → |
| Apr 14, 2026 | Apr 14 8:28 PM | CAROLE HO | Proposed Sale | 87,784 | $30.73 | $2.7M | — | View → |
| Apr 1, 2026 | Apr 6 9:48 PM | John M. EvansDirector, CEO | Sale | 30,078 | $24.58 | $739.3K | 1,047,205(D) | View → |
| Apr 1, 2026 | Apr 6 9:44 PM | Amy SimonChief Medical Officer | Sale | 6,700 | $24.58 | $164.7K | 102,735(D) | View → |
| Apr 1, 2026 | Apr 6 9:39 PM | Bethany J CavanaghSVP, Finance and Treasurer | Sale | 3,242 | $24.58 | $79.7K | 51,171(D) | View → |
| Apr 1, 2026 | Apr 6 9:39 PM | Christine BellonChief Legal Officer | Sale | 5,956 | $24.58 | $146.4K | 109,711(D) | View → |
| Apr 1, 2026 | Apr 6 9:34 PM | Giuseppe CiaramellaPresident | Sale | 11,810 | $24.58 | $290.3K | 218,406(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 93,672(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Amy SimonChief Medical Officer | Grant/Award | 88,500 | $27.62 | 88,500(D) | View → |
← Previous
Page 2 of 2